News
-
-
-
COMMUNIQUÉ DE PRESSE
EV Nickel Announces Positive Mineralogical Results For New Large-Scale Zone
EV Nickel Inc. announces QEMSCAN analysis results on new large-scale zone "Gemini Zone" confirming presence of magmatic sulfides. Focus shifting to higher-grade concentrate potential in 2025 exploration program -
-
-
COMMUNIQUÉ DE PRESSE
APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
APONTIS PHARMA AG waives minimum acceptance condition in Zentiva's public purchase offer. Around 60% shares tendered. Management recommends acceptance. Cash consideration offers premium -
COMMUNIQUÉ DE PRESSE
Original-Research: APONTIS PHARMA AG (von Montega AG): Verkaufen (zuvor: Halten)
Montega AG stuft APONTIS PHARMA AG von Verkaufen auf Halten herab und senkt das Kursziel auf 10,00 EUR. Umsatzprognose gesenkt auf 48,7 Mio. EUR aufgrund verzögerter Wirkung der neuen Vertriebsstrategie -
-
-
COMMUNIQUÉ DE PRESSE
EV Nickel Reports Precious Metals Assays Associated with Elevated Nickel Mineralization in Hole Ev24-Car08 on the CarLang C Zone
EV Nickel Inc. announces significant nickel mineralization with high PGM values in CarLang C area, indicating potential for magmatic sulphide source. Exploration and testing programs ongoing
